Armed robbery in Revesby10h
First-Ever Drug Cuts Heart Attacks, Strokes in Diabetes
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
Science Daily22h
A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
Breakthrough medication significantly cuts risk of heart attacks and strokes: Lancet study
A newly approved drug for type 2 diabetes and kidney disease, sotagliflozin, has shown remarkable benefits in reducing the ...
gastroenterologyadvisor1h
SGLT-2 Inhibitors Reduce Liver Cirrhosis Risk in Type 2 Diabetes
SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.
Light pulses can unlock precise drug activation while minimizing side effects
Acting in the right place at the right time is the key to effective medical treatment with minimal side effects. However, ...
gastroenterologyadvisor2h
Age Differences Seen in Efficacy of Type 2 Diabetes Treatments
HealthDay News — Age differences are seen in the efficacy of treatments for type 2 diabetes, according to a study published online Feb. 3 in the Journal of the American Medical Association.